Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 42

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT04170738Phase 4Completed
Brain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use Disorder
Attention Deficit Disorder With HyperactivityConduct DisorderSubstance Abuse
PrincipalinvestigatorStart date: 2019-11-05
NCT03781765Phase 4Unknown
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
ADHDAttention Deficit Hyperactivity Disorder
PrincipalinvestigatorStart date: 2019-06-04

Research Network

Collaboration Network

5 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Icahn School of Medicine at Mount Sinai

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jeffrey Newcorn, MD

Icahn School of Medicine at Mount Sinai

Moderately Similar
8 trials

Shared therapeutic areas:

Attention Deficit Disorder with HyperactivityConduct DisorderSubstance Abuse

Worked with same sponsors:

Icahn School of Medicine at Mount SinaiJeffrey Newcorn+1 more
Collaborated on 2 trials
Similarity Score38%

Anthony Spirito, PhD

Brown University

Related
10 trials

Shared therapeutic areas:

Conduct DisorderSubstance Abuse
Similarity Score20%

Seetha Shankaran, MD

Wayne State University

Related
49 trials

Shared therapeutic areas:

Substance Abuse

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score10%

Daniel S Pine, M.D.

National Institute of Mental Health (NIMH)

Related
10 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score10%

Abhik Das, PhD

RTI International

Related
31 trials

Shared therapeutic areas:

Substance Abuse

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score10%

Ru-Lan Hsieh, MD

Shin Kong Wu Ho-Su Memorial Hospital

Related
13 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score10%

Sabine Wilhelm, PhD

Massachusetts General Hospital

Related
9 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score10%

Karen Sepucha, PhD

Massachusetts General Hospital

Related
10 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score10%

Roger deBeus, PhD

Skyland Behavioral Health Associates

Related
2 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score10%

Nobuhito Sanada

Otsuka Pharmaceutical Co., Ltd.

Related
11 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04170738Phase 4PrincipalInvestigator

Brain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use Disorder

Attention Deficit Disorder With HyperactivityConduct DisorderSubstance Abuse
Completed
NCT03781765Phase 4PrincipalInvestigator

Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

ADHDAttention Deficit Hyperactivity Disorder
Unknown

All 2 trials loaded